Sex differences in vascular physiology and pathophysiology: Estrogen and androgen signaling in health and disease

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 313, Issue 3, 2017, Pages H524-H545

  Boese, Austin C ^a   Kim, Seong C ^a   Yin, Ke Jie ^b   Lee, Jean Pyo ^a   Hamblin, Milton H ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Androgen receptors; Cardiovascular system; Estrogen receptors; Sex differences; Sex steroid hormones

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; ESTRADIOL; ESTROGEN RECEPTOR; TESTOSTERONE; ANDROGEN; ESTROGEN; SEX HORMONE;

ABDOMINAL AORTIC ANEURYSM; ATHEROSCLEROSIS; BRAIN ARTERY ANEURYSM; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CEREBROVASCULAR ACCIDENT; HEALTH STATUS; HUMAN; HYPERTENSION; MIGRAINE; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSIOLOGICAL PROCESS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SIGNAL TRANSDUCTION; VASCULARIZATION; ANIMAL; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; FEMALE; HEALTH CARE DISPARITY; HEALTH DISPARITY; MALE; METABOLISM;

ANDROGENS; ANIMALS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; ESTROGENS; FEMALE; GONADAL STEROID HORMONES; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HUMANS; MALE; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; SEX FACTORS; SIGNAL TRANSDUCTION;

EID: 85029603289     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00217.2016     Document Type: Review

References (303)

1. Abela OG, Ahsan CH, Alreefi F, Salehi N, Baig I, Janoudi A, Abela GS. Plaque rupture and thrombosis: the value of the atherosclerotic rabbit model in defining the mechanism. Curr Atheroscler Rep 18: 29, 2016. doi:10.1007/s11883-016-0587-0.
2. Abu-Fanne R, Brzezinski A, Golomb M, Grad E, Foldes AJ, Shufaro Y, Varon D, Brill A, Lotan C, Danenberg HD. Effects of estradiol and raloxifene on arterial thrombosis in ovariectomized mice. Menopause 15: 98-104, 2008.
3. Aegidius K, Zwart JA, Hagen K, Schei B, Stovner LJ. Oral contraceptives and increased headache prevalence: the Head-HUNT Study. Neurology 66: 349-353, 2006. doi:10.1212/01.wnl.0000196481.57994.09.
4. Ahlbom E, Prins GS, Ceccatelli S. Testosterone protects cerebellar granule cells from oxidative stress-induced cell death through a receptor mediated mechanism. Brain Res 892: 255-262, 2001. doi:10.1016/S0006-8993(00)03155-3.
5. Ailawadi G, Eliason JL, Roelofs KJ, Sinha I, Hannawa KK, Kaldjian EP, Lu G, Henke PK, Stanley JC, Weiss SJ, Thompson RW, Upchurch GR Jr. Gender differences in experimental aortic aneurysm formation. Arterioscler Thromb Vasc Biol 24: 2116-2122, 2004. doi:10.1161/01.ATV.0000143386.26399.84.
6. Akishita M, Hashimoto M, Ohike Y, Ogawa S, Iijima K, Eto M, Ouchi Y. Low testosterone level is an independent determinant of endothelial dysfunction in men. Hypertens Res 30: 1029-1034, 2007. doi:10.1291/hypres.30.1029.
7. Alcorn HG, Wolfson SK Jr, Sutton-Tyrrell K, Kuller LH, O’Leary D. Risk factors for abdominal aortic aneurysms in older adults enrolled in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 16: 963-970, 1996. doi:10.1161/01.ATV.16.8.963.
8. Alexandersen P, Haarbo J, Byrjalsen I, Lawaetz H, Christiansen C. Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits. Circ Res 84: 813-819, 1999. doi:10.1161/01. RES.84.7.813.
9. Alkayed NJ, Harukuni I, Kimes AS, London ED, Traystman RJ, Hurn PD, Grady PA. Gender-linked brain injury in experimental stroke. Stroke 29: 159-165, 1998. doi:10.1161/01.STR.29.1.159.
10. Allickson JG, Sanchez A, Yefimenko N, Borlongan CV, Sanberg PR. Recent studies assessing the proliferative capability of a novel adult stem cell identified in menstrual blood. Open Stem Cell J 3: 4-10, 2011. doi:10.2174/1876893801103010004.
11. Aloisi AM. Gonadal hormones and sex differences in pain reactivity. Clin J Pain 19: 168-174, 2003. doi:10.1097/00002508-200305000-00004.
12. Anidjar S, Dobrin PB, Chejfec G, Michel JB. Experimental study of determinants of aneurysmal expansion of the abdominal aorta. Ann Vasc Surg 8: 127-136, 1994. doi:10.1007/BF02018860.
13. Appelros P, Stegmayr B, Terent A. Sex differences in stroke epidemiology: a systematic review. Stroke 40: 1082-1090, 2009. doi:10.1161/STROKEAHA.108.540781.
14. Armstrong-Wells J, Johnston SC, Wu YW, Sidney S, Fullerton HJ. Prevalence and predictors of perinatal hemorrhagic stroke: results from the Kaiser pediatric stroke study. Pediatrics 123: 823-828, 2009. doi: 10.1542/peds.2008-0874.
15. Azoulay L, Yin H, Benayoun S, Renoux C, Boivin JF, Suissa S. Androgen-deprivation therapy and the risk of stroke in patients with prostate cancer. Eur Urol 60: 1244-1250, 2011. doi:10.1016/j.eururo. 2011.08.041.
16. Babich EV, Chertok VM, Kotsuba AE. Nitroxidergic neurons in nuclei of the medulla oblongata in hypertensive and normotensive rats. Bull Exp BiolMed 148: 193-195, 2009. doi:10.1007/s10517-009-0671-3.
17. Bakker J, De Mees C, Douhard Q, Balthazart J, Gabant P, Szpirer J, Szpirer C. Alpha-fetoprotein protects the developing female mouse brain from masculinization and defeminization by estrogens. Nat Neurosci 9: 220-226, 2006. doi:10.1038/nn1624.
18. Baron S, Manin M, Beaudoin C, Leotoing L, Communal Y, Veyssiere G, Morel L. Androgen receptor mediates non-genomic activation of phosphatidylinositol 3-OH kinase in androgen-sensitive epithelial cells. J Biol Chem 279: 14579-14586, 2004. doi:10.1074/jbc.M306143200.
19. Barton M. Cholesterol and atherosclerosis: modulation by oestrogen. Curr Opin Lipidol 24: 214-220, 2013. doi:10.1097/MOL.0b013e3283613a94.
20. Barton M. Position paper: the membrane estrogen receptor GPER-clues and questions. Steroids 77: 935-942, 2012. doi:10.1016/j.steroids.2012. 04.001.
21. Bebo BF Jr, Linthicum DS. Expression of mRNA for 55-kDa and 75-kDa tumor necrosis factor (TNF) receptors in mouse cerebrovascular endothelium: effects of interleukin-1 beta, interferon-gamma and TNF-alpha on cultured cells. J Neuroimmunol 62: 161-167, 1995. doi:10.1016/0165-5728(95)00113-5.
22. Bengtsson H, Sonesson B, Bergqvist D. Incidence and prevalence of abdominal aortic aneurysms, estimated by necropsy studies and population screening by ultrasound. Ann N Y Acad Sci 800: 1-24, 1996. doi:10.1111/j.1749-6632.1996.tb33294.x.
23. Bentzon JF, Falk E. Atherosclerotic lesions in mouse and man: is it the same disease? Curr Opin Lipidol 21: 434-40, 2010. doi:10.1097/MOL. 0b013e32833ded6a.
24. Boes T, Levy D. Influence of sex, estrous cycle, and estrogen on intracranial dural mast cells. Cephalalgia 32: 924-931, 2012. doi:10.1177/0333102412454947.
25. Bolay H, Berman NE, Akcali D. Sex-related differences in animal models of migraine headache. Headache 51: 891-904, 2011. doi:10.1111/j.1526-4610.2011.01903.x.
26. Bonduel M, Sciuccati G, Hepner M, Pieroni G, Torres AF, Frontroth JP, Tenembaum S. Arterial ischemic stroke and cerebral venous thrombosis in children: a 12-year Argentinean registry. Acta Haematol 115: 180-185, 2006. doi:10.1159/000090932.
27. Borlongan CV, Cameron DF, Saporta S, Sanberg PR. Intracerebral transplantation of testis-derived sertoli cells promotes functional recovery in female rats with 6-hydroxydopamine-induced hemiparkinsonism. Exp Neurol 148: 388-392, 1997. doi:10.1006/exnr.1997.6513.
28. Bourghardt J, Wilhelmson AS, Alexanderson C, De Gendt K, Verhoeven G, Krettek A, Ohlsson C, Tivesten A. Androgen receptor-dependent and independent atheroprotection by testosterone in male mice. Endocrinology 151: 5428-5437, 2010. doi:10.1210/en.2010-0663.
29. 2 receptor gene expression by oestrogen in apolipoprotein E/oestrogen receptor-alpha knockout mice. Exp Physiol 93: 658-664, 2008. doi:10.1113/expphysiol.2007. 041806.
30. Broughton BR, Miller AA, Sobey CG. Endothelium-dependent relaxation by G protein-coupled receptor 30 agonists in rat carotid arteries. Am J Physiol Heart Circ Physiol 298: H1055-H1061, 2010. doi:10.1152/ajpheart.00878.2009.
31. Bruck B, Brehme U, Gugel N, Hanke S, Finking G, Lutz C, Benda N, Schmahl FW, Haasis R, Hanke H. Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 17: 2192-2199, 1997. doi:10.1161/01.ATV.17.10.2192.
32. Brunsing RL, Owens KS, Prossnitz ER. The G protein-coupled estrogen receptor (GPER) agonist G-1 expands the regulatory T-cell population under TH17-polarizing conditions. J Immunother 36: 190-196, 2013. doi:10.1097/CJI.0b013e31828d8e3b.
33. Brunsing RL, Prossnitz ER. Induction of interleukin-10 in the T helper type 17 effector population by the G protein coupled estrogen receptor (GPER) agonist G-1. Immunology 134: 93-106, 2011. doi:10.1111/j. 1365-2567.2011.03471.x.
34. Burleson AC, Turitto VT. Identification of quantifiable hemodynamic factors in the assessment of cerebral aneurysm behavior. On behalf of the Subcommittee on Biorheology of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 76: 118-123, 1996.
35. Burns KA, Korach KS. Estrogen receptors and human disease: an update. Arch Toxicol 86: 1491-1504, 2012. doi:10.1007/s00204-012-0868-5.
36. Cairrâo E, Alvarez E, Santos-Silva AJ, Verde I. Potassium channels are involved in testosterone-induced vasorelaxation of human umbilical artery. Naunyn Schmiedebergs Arch Pharmacol 376: 375-383, 2008. doi:10.1007/s00210-007-0213-3.
37. Calderon-Margalit R, Siscovick D, Merkin SS, Wang E, Daviglus ML, Schreiner PJ, Sternfeld B, Williams OD, Lewis CE, Azziz R, Schwartz SM, Wellons MF. Prospective association of polycystic ovary syndrome with coronary artery calcification and carotid-intima-media thickness: the Coronary Artery Risk Development in Young Adults Women’s study. Arterioscler Thromb Vasc Biol 34: 2688-2694, 2014. doi:10.1161/ATVBAHA.114.304136.
38. Calhoun A, Ford S, Pruitt A. The impact of extended-cycle vaginal ring contraception on migraine aura: a retrospective case series. Headache 52: 1246-1253, 2012. doi:10.1111/j.1526-4610.2012.02211.x.
39. Campa JS, Greenhalgh RM, Powell JT. Elastin degradation in abdominal aortic aneurysms. Atherosclerosis 65: 13-21, 1987. doi:10.1016/0021-9150(87)90003-7.
40. Carroll JE, Howard EF, Hess DC, Wakade CG, Chen Q, Cheng C. Nuclear factor-kappa B activation during cerebral reperfusion: effect of attenuation with N-acetylcysteine treatment. Brain Res Mol Brain Res 56: 186-191, 1998. doi:10.1016/S0169-328X(98)00045-X.
41. Caruso A, Di Giorgi Gerevini V, Castiglione M, Marinelli F, Tomassini V, Pozzilli C, Caricasole A, Bruno V, Caciagli F, Moretti A, Nicoletti F, Melchiorri D. Testosterone amplifies excitotoxic damage of cultured oligodendrocytes. J Neurochem 88: 1179-1185, 2004. doi:10.1046/j.1471-4159.2004.02284.x.
42. Cassis LA, Rateri DL, Lu H, Daugherty A. Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms. Arterioscler Thromb Vasc Biol 27: 380-386, 2007. doi:10.1161/01.ATV.0000254680.71485.92.
43. Castoria G, D’Amato L, Ciociola A, Giovannelli P, Giraldi T, Sepe L, Paolella G, Barone MV, Migliaccio A, Auricchio F. Androgen-induced cell migration: role of androgen receptor/filamin A association. PLoS One 6: e17218, 2011. doi:10.1371/journal.pone.0017218.
44. Chakrabarti S, Davidge ST. G-protein coupled receptor 30 (GPR30): a novel regulator of endothelial inflammation. PLoS One 7: e52357, 2012. doi:10.1371/journal.pone.0052357.
45. Chambliss KL, Wu Q, Oltmann S, Konaniah ES, Umetani M, Korach KS, Thomas GD, Mineo C, Yuhanna IS, Kim SH, Madak-Erdogan Z, Maggi A, Dineen SP, Roland CL, Hui DY, Brekken RA, Katzenellenbogen JA, Katzenellenbogen BS, Shaul PW. Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. J Clin Invest 120: 23192330, 2010. doi:10.1172/JCI38291.
46. Channer KS, Jones TH. Cardiovascular effects of testosterone: implications of the “male menopause”? Heart 89: 121-122, 2003. doi:10.1136/heart.89.2.121.
47. Chen YF, Naftilan AJ, Oparil S. Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats. Hypertension 19: 456-463, 1992. doi:10.1161/01.HYP.19.5.456.
48. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103: 401-406, 1999. doi:10.1172/JCI5347.
49. Cheng J, Alkayed NJ, Hurn PD. Deleterious effects of dihydrotestosterone on cerebral ischemic injury. J Cereb Blood Flow Metab 27: 1553-1562, 2007. doi:10.1038/sj.jcbfm.9600457.
50. Cheng J, Uchida M, Zhang W, Grafe MR, Herson PS, Hurn PD. Role of salt-induced kinase 1 in androgen neuroprotection against cerebral ischemia. J Cereb Blood Flow Metab 31: 339-350, 2011. doi:10.1038/jcbfm.2010.98.
51. Cho BS, Woodrum DT, Roelofs KJ, Stanley JC, Henke PK, Upchurch GR Jr. Differential regulation of aortic growth in male and female rodents is associated with AAA development. J Surg Res 155: 330-338, 2009. doi:10.1016/j.jss.2008.07.027.
52. Cohen-Bendahan CC, van de Beek C, Berenbaum SA. Prenatal sex hormone effects on child and adult sex-typed behavior: methods and findings. Neurosci Biobehav Rev 29: 353-384, 2005. doi:10.1016/j. neubiorev.2004.11.004.
53. Colin S, Chinetti-Gbaguidi G, Staels B. Macrophage phenotypes in atherosclerosis. Immunol Rev 262: 153-166, 2014. doi:10.1111/imr. 12218.
54. Colvin PL Jr. Estrogen increases low-density lipoprotein receptor-independent catabolism of apolipoprotein B in hyperlipidemic rabbits. Metabolism 45: 889-896, 1996. doi:10.1016/S0026-0495(96)90165-1.
55. Cooper SA, Whaley-Connell A, Habibi J, Wei Y, Lastra G, Manrique C, Stas S, Sowers JR. Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. Am J Physiol Heart Circ Physiol 293: H2009-H2023, 2007. doi:10.1152/ajpheart.00522.2007.
56. Cornil CA, Ball GF, Balthazart J. Functional significance of the rapid regulation of brain estrogen action: where do the estrogens come from? Brain Res 1126: 2-26, 2006. doi:10.1016/j.brainres.2006.07.098.
57. Cui G, Wang H, Li R, Zhang L, Li Z, Wang Y, Hui R, Ding H, Wang DW. Polymorphism of tumor necrosis factor alpha (TNF-alpha) gene promoter, circulating TNF-alpha level, and cardiovascular risk factor for ischemic stroke. J Neuroinflammation 9: 235, 2012. doi:10.1186/1742-2094-9-235.
58. Culmsee C, Siewe J, Junker V, Retiounskaia M, Schwarz S, Camandola S, El-Metainy S, Behnke H, Mattson MP, Krieglstein J. Reciprocal inhibition of p53 and nuclear factor-kappaB transcriptional activities determines cell survival or death in neurons. J Neurosci 23: 85868595, 2003.
59. Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, Davis V, Gutierrez-Ramos JC, Connelly PW, Milstone DS. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 107: 1255-1262, 2001. doi:10.1172/JCI11871.
60. Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 105: 1605-1612, 2000. doi:10.1172/JCI7818.
61. Davies MR, Lund RJ, Mathew S, Hruska KA. Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome. J Am Soc Nephrol 16: 917-928, 2005. doi:10.1681/ASN. 2004100835.
62. Davis DD, Ruiz AL, Yanes LL, Iliescu R, Yuan K, Moulana M, Racusen LC, Reckelhoff JF. Testosterone supplementation in male obese Zucker rats reduces body weight and improves insulin sensitivity but increases blood pressure. Hypertension 59: 726-731, 2012. doi:10.1161/HYPERTENSIONAHA.111.180943.
63. de Rooij NK, Linn FH, van der Plas JA, Algra A, Rinkel GJ. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry 78: 1365-1372, 2007. doi:10.1136/jnnp.2007.117655.
64. Death AK, McGrath KC, Sader MA, Nakhla S, Jessup W, Handelsman DJ, Celermajer DS. Dihydrotestosterone promotes vascular cell adhesion molecule-1 expression in male human endothelial cells via a nuclear factor-kappaB-dependent pathway. Endocrinology 145: 18891897, 2004. doi:10.1210/en.2003-0789.
65. Demirbag R, Yilmaz R, Ulucay A, Unlu D. The inverse relationship between thoracic aortic intima media thickness and testosterone level. Endocr Res 31: 335-344, 2005. doi:10.1080/07435800500449494.
66. Deroo BJ, Buensuceso AV. Minireview: Estrogen receptor-beta: mechanistic insights from recent studies. Mol Endocrinol 24: 1703-1714, 2010. doi:10.1210/me.2009-0288.
67. DiMusto PD, Lu G, Ghosh A, Roelofs KJ, Su G, Zhao Y, Lau CL, Sadiq O, McEvoy B, Laser A, Diaz JA, Wakefield TW, Henke PK, Eliason JL, Upchurch GR Jr. Increased PAI-1 in females compared with males is protective for abdominal aortic aneurysm formation in a rodent model. Am J Physiol Heart Circ Physiol 302: H1378-H1386, 2012. doi:10.1152/ajpheart.00620.2011.
68. Dinapoli VA, Benkovic SA, Li X, Kelly KA, Miller DB, Rosen CL, Huber JD, O’Callaghan JP. Age exaggerates proinflammatory cytokine signaling and truncates signal transducers and activators of transcription 3 signaling following ischemic stroke in the rat. Neuroscience 170: 633-644, 2010. doi:10.1016/j.neuroscience.2010.07.011.
69. Dopp JM, Mackenzie-Graham A, Otero GC, Merrill JE. Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia. J Neuroimmunol 75: 104-112, 1997. doi:10.1016/S0165-5728(97)00009-X.
70. Dudek EJ, Shang F, Taylor A. H(2)O(2)-mediated oxidative stress activates NF-kappa B in lens epithelial cells. Free Radic Biol Med 31: 651-658, 2001. doi:10.1016/S0891-5849(01)00634-7.
71. Dziewulska D, Mossakowski MJ. Cellular expression of tumor necrosis factor a and its receptors in human ischemic stroke. Clin Neuropathol 22: 35-40, 2003.
72. Ebenbichler CF, Sturm W, Gänzer H, Bodner J, Mangweth B, Ritsch A, Sandhofer A, Lechleitner M, Föger B, Patsch JR. Flowmediated, endothelium-dependent vasodilatation is impaired in male body builders taking anabolic-androgenic steroids. Atherosclerosis 158: 483-490, 2001. doi:10.1016/S0021-9150(01)00465-8.
73. Eckert A, Huang L, Gonzalez R, Kim HS, Hamblin MH, Lee JP. Bystander effect fuels human induced pluripotent stem cell-derived neural stem cells to quickly attenuate early stage neurological deficits after stroke. Stem Cells Transl Med 4: 841-851, 2015. doi:10.5966/sctm. 2014-0184.
74. Emanuele MA, Wezeman F, Emanuele NV. Alcohol’s effects on female reproductive function. Alcohol Res Health 26: 274-281, 2002.
75. Emmanouil M, Taoufik E, Tseveleki V, Vamvakas SS, Probert L. A role for neuronal NF-κB in suppressing neuroinflammation and promoting neuroprotection in the CNS. Adv Exp Med Biol 691: 575-581, 2011. doi: 10.1007/978-1-4419-6612-4_60.
76. Fairweather D, Petri MA, Coronado MJ, Cooper LT. Autoimmune heart disease: role of sex hormones and autoantibodies in disease pathogenesis. Expert Rev Clin Immunol 8: 269-284, 2012. doi:10.1586/eci. 12.10.
77. Figiel I, Dzwonek K. TNFalpha and TNF receptor 1 expression in the mixed neuronal-glial cultures of hippocampal dentate gyrus exposed to glutamate or trimethyltin. Brain Res 1131: 17-28, 2007. doi:10.1016/j. brainres.2006.10.095.
78. Filardo EJ, Thomas P. Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology. Endocrinology 153: 2953-2962, 2012. doi:10.1210/en.2012-1061.
79. Fischer M, Baessler A, Schunkert H. Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res 53: 672-677, 2002. doi:10.1016/S0008-6363(01)00479-5.
80. Foehr ED, Lin X, O’Mahony A, Geleziunas R, Bradshaw RA, Greene WC. NF-kappa B signaling promotes both cell survival and neurite process formation in nerve growth factor-stimulated PC12 cells. J Neurosci 20: 7556-7563, 2000.
81. Foradori CD, Weiser MJ, Handa RJ. Non-genomic actions of androgens. Front Neuroendocrinol 29: 169-181, 2008. doi:10.1016/j.yfrne. 2007.10.005.
82. Foradori CD, Werner SB, Sandau US, Clapp TR, Handa RJ. Activation of the androgen receptor alters the intracellular calcium response to glutamate in primary hippocampal neurons and modulates sarco/endoplasmic reticulum calcium ATPase 2 transcription. Neuroscience 149: 155-164, 2007. doi:10.1016/j.neuroscience.2007.06.054.
83. Freeman EW, Sammel MD, Lin H, Gracia CR, Kapoor S. Symptoms in the menopausal transition: hormone and behavioral correlates. Obstet Gynecol 111: 127-136, 2008. doi:10.1097/01.AOG.0000295867. 06184.b1.
84. Fukuda M, Kanda T, Kamide N, Akutsu T, Sakai F. Gender differences in long-term functional outcome after first-ever ischemic stroke. Intern Med 48: 967-973, 2009. doi:10.2169/internalmedicine.48.1757.
85. Gardner G, Banka CL, Roberts KA, Mullick AE, Rutledge JC. Modified LDL-mediated increases in endothelial layer permeability are attenuated with 17 beta-estradiol. Arterioscler Thromb Vasc Biol 19: 854-861, 1999. doi:10.1161/01.ATV.19.4.854.
86. Georget V, Térouanne B, Nicolas JC, Sultan C. Mechanism of antiandrogen action: key role of hsp90 in conformational change and transcriptional activity of the androgen receptor. Biochemistry 41: 1182411831, 2002. doi:10.1021/bi0259150.
87. Geraldes P, Gagnon S, Hadjadj S, Merhi Y, Sirois MG, Cloutier I, Tanguay JF. Estradiol blocks the induction of CD40 and CD40L expression on endothelial cells and prevents neutrophil adhesion: an ERalpha-mediated pathway. Cardiovasc Res 71: 566-573, 2006. doi:10.1016/j.cardiores.2006.05.015.
88. Ghosh A, Lu G, Su G, McEvoy B, Sadiq O, DiMusto PD, Laser A, Futchko JS, Henke PK, Eliason JL, Upchurch GR Jr. Phosphorylation of AKT and abdominal aortic aneurysm formation. Am J Pathol 184: 148-158, 2014. doi:10.1016/j.ajpath.2013.09.016.
89. Gilliver SC. Sex steroids as inflammatory regulators. J Steroid Biochem Mol Biol 120: 105-115, 2010. doi:10.1016/j.jsbmb.2009.12.015.
90. Gingerich S, Krukoff TL. Estrogen in the paraventricular nucleus attenuates L-glutamate-induced increases in mean arterial pressure through estrogen receptor beta and NO. Hypertension 48: 1130-1136, 2006. doi:10.1161/01.HYP.0000248754.67128.ff.
91. Glass CK, Rosenfeld MG. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14: 121-141, 2000.
92. Goldstein JL, Brown MS. The LDL receptor defect in familial hypercholesterolemia. Implications for pathogenesis and therapy. Med Clin NorthAm 66: 335-362, 1982. doi:10.1016/S0025-7125(16)31424-9.
93. Golomb MR, Dick PT, MacGregor DL, Curtis R, Sofronas M, deVeber GA. Neonatal arterial ischemic stroke and cerebral sinovenous thrombosis are more commonly diagnosed in boys. J Child Neurol 19: 493-497, 2004. doi:10.1177/08830738040190070301.
94. Golomb MR, Fullerton HJ, Nowak-Gottl U, Deveber G; International Pediatric Stroke Study Group. Male predominance in childhood ischemic stroke: findings from the international pediatric stroke study. Stroke 40: 52-57, 2009. doi:10.1161/STROKEAHA.108.521203.
95. Greco R, Tassorelli C, Mangione AS, Smeraldi A, Allena M, Sandrini G, Nappi G, Nappi RE. Effect of sex and estrogens on neuronal activation in an animal model of migraine. Headache 53: 288-296, 2013. doi:10.1111/j.1526-4610.2012.02249.x.
96. Gros R, Ding Q, Liu B, Chorazyczewski J, Feldman RD. Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation. Am J Physiol Cell Physiol 304: C532-C540, 2013. doi:10.1152/ajpcell.00203.2012.
97. Haas E, Bhattacharya I, Brailoiu E, Damjanović M, Brailoiu GC, Gao X, Mueller-Guerre L, Marjon NA, Gut A, Minotti R, Meyer MR, Amann K, Ammann E, Perez-Dominguez A, Genoni M, Clegg DJ, Dun NJ, Resta TC, Prossnitz ER, Barton M. Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ Res 104: 288-291, 2009. doi:10.1161/CIRCRESAHA.108.190892.
98. Haas E, Meyer MR, Schurr U, Bhattacharya I, Minotti R, Nguyen HH, Heigl A, Lachat M, Genoni M, Barton M. Differential effects of 17beta-estradiol on function and expression of estrogen receptor alpha, estrogen receptor beta, and GPR30 in arteries and veins of patients with atherosclerosis. Hypertension 49: 1358-1363, 2007. doi:10.1161/HYPERTENSIONAHA.107.089995.
99. Hall ED, Pazara KE, Linseman KL. Sex differences in postischemic neuronal necrosis in gerbils. J Cereb Blood Flow Metab 11: 292-298, 1991. doi:10.1038/jcbfm.1991.61.
100. 2+ channels in A7r5 cells by physiological levels of testosterone. Endocrinology 147: 2675-2680, 2006. doi:10.1210/en. 2005-1243.
101. Hammes SR, Levin ER. Extranuclear steroid receptors: nature and actions. Endocr Rev 28: 726-741, 2007. doi:10.1210/er.2007-0022.
102. Hansson GK, Hermansson A. The immune system in atherosclerosis. Natlmmunol 12: 204-212, 2011. doi:10.1038/ni.2001.
103. Haring R, Travison TG, Bhasin S, Vasan RS, Wallaschofski H, Davda MN, Coviello A, Murabito JM. Relation between sex hormone concentrations, peripheral arterial disease, and change in ankle-brachial index: findings from the Framingham Heart Study. J Clin Endocrinol Metab 96: 3724-3732, 2011. doi:10.1210/jc.2011-1068.
104. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 24, Suppl 1: 9-160, 2004.
105. Heinlein CA, Chang C. Androgen receptor (AR) coregulators: an overview. Endocr Rev 23: 175-200, 2002. doi:10.1210/edrv.23.2.0460.
106. Heinlein CA, Chang C. The roles of androgen receptors and androgenbinding proteins in nongenomic androgen actions. Mol Endocrinol 16: 2181-2187, 2002. doi:10.1210/me.2002-0070.
107. Henriques TA, Huang J, D’Souza SS, Daugherty A, Cassis LA. Orchidectomy, but not ovariectomy, regulates angiotensin II-induced vascular diseases in apolipoprotein E-deficient mice. Endocrinology 145: 3866-3872, 2004. doi:10.1210/en.2003-1615.
108. Hernandez Schulman I, Raij L. Salt sensitivity and hypertension after menopause: role of nitric oxide and angiotensin II. Am J Nephrol 26: 170-180, 2006. doi:10.1159/000092984.
109. Higashiura K, Mathur RS, Halushka PV. Gender-related differences in androgen regulation of thromboxane A2 receptors in rat aortic smoothmuscle cells. J Cardiovasc Pharmacol 29: 311-315, 1997. doi:10.1097/00005344-199703000-00002.
110. Hill CA, Fitch RH. Sex differences in mechanisms and outcome of neonatal hypoxia-ischemia in rodent models: implications for sex-specific neuroprotection in clinical neonatal practice. Neurol Res Int 2012: 867531, 2012. doi:10.1155/2012/867531.
111. Hines M. Early androgen influences on human neural and behavioural development. Early Hum Dev 84: 805-807, 2008. doi:10.1016/j. earlhumdev.2008.09.006.
112. Hintz SR, Kendrick DE, Vohr BR, Kenneth Poole W, Higgins RD; NICHD Neonatal Research Network. Gender differences in neurodevelopmental outcomes among extremely preterm, extremely-low-birth-weight infants. Acta Paediatr 95: 1239-1248, 2006. doi:10.1080/08035250600599727.
113. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM Jr, White CJ, White J, White RA, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B; American Association for Vascular Surgery/Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC/AHA Task Force on Practice Guidelines Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease; American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; Vascular Disease Foundation. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 113: e463-e654, 2006. doi:10.1161/CIRCULATIONAHA.106.174526.
114. Hodgin JB, Krege JH, Reddick RL, Korach KS, Smithies O, Maeda N. Estrogen receptor alpha is a major mediator of 17beta-estradiol’s atheroprotective effects on lesion size in Apoe-/- mice. J Clin Invest 107: 333-340, 2001. doi:10.1172/JCI11320.
115. Holmes S, Abbassi B, Su C, Singh M, Cunningham RL. Oxidative stress defines the neuroprotective or neurotoxic properties of androgens in immortalized female rat dopaminergic neuronal cells. Endocrinology 154: 4281-4292, 2013. doi:10.1210/en.2013-1242.
116. Hu W, Polinsky P, Sadoun E, Rosenfeld ME, Schwartz SM. Atherosclerotic lesions in the common coronary arteries of ApoE knockout mice. CardiovascPathol 14:120-125, 2005. doi:10.1016/j.carpath.2005. 02.004.
117. Huang L, Wong S, Snyder EY, Hamblin MH, Lee JP. Human neural stem cells rapidly ameliorate symptomatic inflammation in early-stage ischemic-reperfusion cerebral injury. Stem Cell Res Ther 5: 129, 2014. doi:10.1186/scrt519.
118. Ingelfinger JR. Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease. Curr Opin Nephrol Hypertens 18: 79-84, 2009. doi:10.1097/MNH.0b013e32831b70ad.
119. Ishunina TA, Sluiter AA, Swaab DF, Verwer RW. Transcriptional activity of human brain estrogen receptor-a splice variants: evidence for cell type-specific regulation. Brain Res 1500: 1-9, 2013. doi:10.1016/j. brainres.2012.12.050.
120. Iwakura A, Luedemann C, Shastry S, Hanley A, Kearney M, Aikawa R, Isner JM, Asahara T, Losordo DW. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 108: 3115-3121, 2003. doi:10.1161/01.CIR. 0000106906.56972.83.
121. Iwakura A, Shastry S, Luedemann C, Hamada H, Kawamoto A, Kishore R, Zhu Y, Qin G, Silver M, Thorne T, Eaton L, Masuda H, Asahara T, Losordo DW. Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9. Circulation 113: 1605-1614, 2006. doi: 10.1161/CIRCULATIONAHA.105.553925.
122. Jackson EA, Munir K, Schreiber T, Rubin JR, Cuff R, Gallagher KA, Henke PK, Gurm HS, Grossman PM. Impact of sex on morbidity and mortality rates after lower extremity interventions for peripheral arterial disease: observations from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. J Am Coll Cardiol 63: 2525-2530, 2014. doi:10.1016/j.jacc.2014.03.036.
123. Ji H, Menini S, Zheng W, Pesce C, Wu X, Sandberg K. Role of angiotensin-converting enzyme 2 and angiotensin(1-7) in 17beta-oestra-diol regulation of renal pathology in renal wrap hypertension in rats. Exp Physiol 93: 648-657, 2008. doi:10.1113/expphysiol.2007.041392.
124. Jin HJ, Kim J, Yu J. Androgen receptor genomic regulation. Transi Androl Urol 2: 157-177, 2013. doi:10.3978/j.issn.2223-4683.2013. 09.01.
125. Johnston MV, Hagberg H. Sex and the pathogenesis of cerebral palsy. Dev Med ChildNeurol 49: 74-78, 2007. doi:10.1017/S0012162207000199.x.
126. Kamada M, Irahara M, Maegawa M, Ohmoto Y, Takeji T, Yasui T, Aono T. Postmenopausal changes in serum cytokine levels and hormone replacement therapy. Am J Obstet Gynecol 184: 309-314, 2001. doi:10.1067/mob.2001.109940.
127. Khaw KT, Dowsett M, Folkerd E, Bingham S, Wareham N, Luben R, Welch A, Day N. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation 116: 2694-2701, 2007. doi:10.1161/CIRCULATIONAHA.107.719005.
128. Khoury JC, Kleindorfer D, Alwell K, Moomaw CJ, Woo D, Adeoye O, Flaherty ML, Khatri P, Ferioli S, Broderick JP, Kissela BM. Diabetes mellitus: a risk factor for ischemic stroke in a large biracial population. Stroke 44: 1500-1504, 2013. doi:10.1161/STROKEAHA. 113.001318.
129. Kienitz T, Quinkler M. Testosterone and blood pressure regulation. Kidney Blood Press Res 31: 71-79, 2008. doi:10.1159/000119417.
130. Kim KH, Moriarty K, Bender JR. Vascular cell signaling by membrane estrogen receptors. Steroids 73: 864-869, 2008. doi:10.1016/j. steroids.2008.01.008.
131. Knopp RH, Paramsothy P, Retzlaff BM, Fish B, Walden C, Dowdy A, Tsunehara C, Aikawa K, Cheung MC. Sex differences in lipoprotein metabolism and dietary response: basis in hormonal differences and implications for cardiovascular disease. Curr Cardiol Rep 8: 452-459, 2006. doi:10.1007/s11886-006-0104-0.
132. Koizumi H, Yu J, Hashimoto R, Ouchi Y, Okabe T. Involvement of androgen receptor in nitric oxide production induced by icariin in human umbilical vein endothelial cells. FEBS Lett 584: 2440-2444, 2010. doi:10.1016/j.febslet.2010.04.049.
133. Komukai K, Mochizuki S, Yoshimura M. Gender and the renin-angiotensin-aldosterone system. Fundam Clin Pharmacol 24: 687-698, 2010. doi:10.1111/j.1472-8206.2010.00854.x.
134. Lambertsen KL, Biber K, Finsen B. Inflammatory cytokines in experimental and human stroke. J Cereb Blood Flow Metab 32: 1677-1698, 2012. doi:10.1038/jcbfm.2012.88.
135. Lan WC, Priestley M, Mayoral SR, Tian L, Shamloo M, Penn AA. Sex-specific cognitive deficits and regional brain volume loss in mice exposed to chronic, sublethal hypoxia. Pediatr Res 70: 15-20, 2011. doi:10.1203/PDR.0b013e31821b98a3.
136. Laser A, Ghosh A, Roelofs K, Sadiq O, McEvoy B, DiMusto P, Eliason J, Upchurch GR Jr. Increased estrogen receptor alpha expression in experimental aortic aneurysms in females compared with males. JSurg Res 186: 467-474, 2014. doi:10.1016/j.jss.2013.07.050.
137. Laughlin GA, Barrett-Connor E, Bergstrom J. Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 93: 68-75, 2007. doi:10.1210/jc.2007-1792.
138. Lavoie JL, Sigmund CD. Minireview: overview of the renin-angiotensin system-an endocrine and paracrine system. Endocrinology 144: 2179-2183, 2003. doi:10.1210/en.2003-0150.
139. Lee JK, Borhani M, Ennis TL, Upchurch GR Jr, Thompson RW. Experimental abdominal aortic aneurysms in mice lacking expression of inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol 21: 1393-1401, 2001. doi:10.1161/hq0901.095750.
140. Levin ER. G protein-coupled receptor 30: estrogen receptor or collaborator? Endocrinology 150: 1563-1565, 2009. doi:10.1210/en.2008-1759.
141. Lewis DK, Thomas KT, Selvamani A, Sohrabji F. Age-related severity of focal ischemia in female rats is associated with impaired astrocyte function. Neurobiol Aging 33: 1123.e1-1123.e16, 2012. doi:10.1016/j. neurobiolaging.2011.11.007.
142. Li F, Yu X, Szynkarski CK, Meng C, Zhou B, Barhoumi R, White RE, Heaps CL, Stallone JN, Han G. Activation of GPER induces differentiation and inhibition of coronary artery smooth muscle cell proliferation. PLoS One 8: e64771, 2013. doi:10.1371/journal.pone. 0064771.
143. Liao SL, Chen WY, Chen CJ. Estrogen attenuates tumor necrosis factor-alpha expression to provide ischemic neuroprotection in female rats. Neurosci Lett 330: 159-162, 2002. doi:10.1016/S0304-3940(02) 00754-1.
144. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104: 365-372, 2001. doi:10.1161/01.CIR.104.3. 365.
145. Lindsey SH, Carver KA, Prossnitz ER, Chappell MC. Vasodilation in response to the GPR30 agonist G-1 is not different from estradiol in the mRen2.Lewis female rat. J Cardiovasc Pharmacol 57: 598-603, 2011. doi:10.1097/FJC.0b013e3182135f1c.
146. Lindsey SH, Cohen JA, Brosnihan KB, Gallagher PE, Chappell MC. Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats. Endocrinology 150: 3753-3758, 2009. doi:10.1210/en.2008-1664.
147. Lipton RB, Bigal ME. Migraine: epidemiology, impact, and risk factors for progression. Headache 45, Suppl 1: S3-S13, 2005. doi:10.1111/j. 1526-4610.2005.4501001.x.
148. Liu F, McCullough LD. Interactions between age, sex, and hormones in experimental ischemic stroke. Neurochem Int 61: 1255-1265, 2012. doi:10.1016/j.neuint.2012.10.003.
149. Liu F, Yuan R, Benashski SE, McCullough LD. Changes in experimental stroke outcome across the life span. J Cereb Blood Flow Metab 29: 792-802, 2009. doi:10.1038/jcbfm.2009.5.
150. Liu J, Ji H, Zheng W, Wu X, Zhu JJ, Arnold AP, Sandberg K. Sex differences in renal angiotensin converting enzyme 2 (ACE2) activity are 17p-oestradiol-dependent and sex chromosome-independent. Biol Sex Differ 1: 6, 2010. doi:10.1186/2042-6410-1-6.
151. Liu PY, Death AK, Handelsman DJ. Androgens and cardiovascular disease. Endocr Rev 24: 313-340, 2003. doi:10.1210/er.2003-0005.
152. Lo W, Stephens J, Fernandez S. Pediatric stroke in the United States and the impact of risk factors. J Child Neurol 24: 194-203, 2009. doi:10.1177/0883073808322665.
153. Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 89: 1501-1510, 1994. doi:10.1161/01.CIR.89.4.1501.
154. Loy CJ, Sim KS, Yong EL. Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functions. Proc Natl Acad Sci USA 100: 4562-4567, 2003. doi:10.1073/pnas.0736237100.
155. Lu ML, Schneider MC, Zheng Y, Zhang X, Richie JP. Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J Biol Chem 276: 13442-13451, 2001. doi:10.1074/jbc.M006598200.
156. Lu Q, Pallas DC, Surks HK, Baur WE, Mendelsohn ME, Karas RH. Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha. Proc Natl Acad Sci USA 101: 17126-17131, 2004. doi:10.1073/pnas.0407492101.
157. MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology 67: 2154-2158, 2006. doi:10.1212/01.wnl. 0000233888.18228.19.
158. Macìas G, Merki-Feld GS, Parke S, Mellinger U, Serrani M. Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: results from the multicentre, randomised, double-blind, active-controlled HARMONY II study. J Obstet Gynaecol 33: 591-596, 2013. doi:10.3109/01443615.2013.800851.
159. Maggio M, Cattabiani C, Lauretani F, Artoni A, Bandinelli S, Schiavi G, Vignali A, Volpi R, Ceresini G, Lippi G, Aloe R, De Vita F, Giallauria F, McDermott MM, Ferrucci L, Ceda GP. The relationship between sex hormones, sex hormone binding globulin and peripheral artery disease in older persons. Atherosclerosis 225: 469-474, 2012. doi:10.1016/j.atherosclerosis.2012.09.014.
160. Mahmoodzadeh S, Leber J, Zhang X, Jaisser F, Messaoudi S, Morano I, Furth PA, Dworatzek E, Regitz-Zagrosek V. Cardiomyocyte-specific estrogen receptor alpha increases angiogenesis, lymphangiogenesis and reduces fibrosis in the female mouse heart post-myocardial infarction. J Cell Sci Ther 5: 153, 2014. doi:10.4172/2157-7013. 1000153.
161. Mäkinen J, Järvisalo MJ, Pöllänen P, Perheentupa A, Irjala K, Koskenvuo M, Mäkinen J, Huhtaniemi I, Raitakari OT. Increased carotid atherosclerosis in andropausal middle-aged men. J Am Coll Cardiol 45: 1603-1608, 2005. doi:10.1016/j.jacc.2005.01.052.
162. Malan NT, Smith W, von Känel R, Hamer M, Schutte AE, Malan L. Low serum testosterone and increased diastolic ocular perfusion pressure: a risk for retinal microvasculature. Vasa 44: 435-443, 2015. doi:10.1024/0301-1526/a000466.
163. Manning MW, Cassi LA, Huang J, Szilvassy SJ, Daugherty A. Abdominal aortic aneurysms: fresh insights from a novel animal model of the disease. VascMed 7: 45-54, 2002. doi:10.1191/1358863x02vm413ra.
164. Manning MW, Cassis LA, Daugherty A. Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 23: 483-488, 2003. doi:10.1161/01.ATV. 0000058404.92759.32.
165. Manwani B, Liu F, Scranton V, Hammond MD, Sansing LH, McCullough LD. Differential effects of aging and sex on stroke induced inflammation across the lifespan. Exp Neurol 249: 120-131, 2013. doi:10.1016/j.expneurol.2013.08.011.
166. Manwani B, McCullough LD. Estrogen in ischaemic stroke: the debate continues. EurJNeurol 19: 1276-1277, 2012. doi:10.1111/j.1468-1331. 2012.03746.x.
167. Mårin P, Holmäng S, Gustafsson C, Jönsson L, Kvist H, Elander A, Eldh J, Sjöström L, Holm G, Björntorp P. Androgen treatment of abdominally obese men. ObesRes 1: 245-251, 1993. doi:10.1002/j.1550-8528.1993.tb00618.x.
168. Massart F, Marini F, Menegato A, Del Monte F, Nuti M, Butitta F, Ferrari M, Balbarini A, Brandi ML. Allelic genes involved in artery compliance and susceptibility to sporadic abdominal aortic aneurysm. J Steroid Biochem Mol Biol 92: 413-418, 2004. doi:10.1016/j.jsbmb.2004. 10.010.
169. Matsubara K, Harada H, Ando N, Watada S, Obara H, Matsumoto K, Kitagawa Y. Estrogen deficiency attenuates neovascularization in a murine model of hindlimb ischemia. J Surg Res 178: 1022-1028, 2012. doi:10.1016/j.jss.2012.04.067.
170. Matthews JR, Hay RT. Regulation of the DNA binding activity of NF-kappa B. Int J Biochem Cell Biol 27: 865-879, 1995. doi:10.1016/1357-2725(95)00071-V.
171. McCrohon JA, Death AK, Nakhla S, Jessup W, Handelsman DJ, Stanley KK, Celermajer DS. Androgen receptor expression is greater in macrophages from male than from female donors. A sex difference with implications for atherogenesis. Circulation 101: 224-226, 2000. doi:10.1161/01.CIR.101.3.224.
172. McCrohon JA, Jessup W, Handelsman DJ, Celermajer DS. Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1. Circulation 99: 2317-2322, 1999. doi:10.1161/01.CIR.99.17.2317.
173. McGuire BB, Watson RW, Pérez-Barriocanal F, Fitzpatrick JM, Docherty NG. Gender differences in the renin-angiotensin and nitric oxide systems: relevance in the normal and diseased kidney. Kidney Blood Press Res 30: 67-80, 2007. doi:10.1159/000099150.
174. McKinley MJ, Albiston AL, Allen AM, Mathai ML, May CN, McAllen RM, Oldfield BJ, Mendelsohn FA, Chai SY. The brain renin-angiotensin system: location and physiological roles. Int J Biochem Cell Biol 35: 901-918, 2003. doi:10.1016/S1357-2725(02)00306-0.
175. Mendelsohn ME. Genomic and nongenomic effects of estrogen in the vasculature. Am J Cardiol 90, 1A: 3F-6F, 2002. doi:10.1016/S0002-9149(02)02418-9.
176. Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science 308: 1583-1587, 2005. doi:10.1126/science.1112062.
177. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 340: 1801-1811, 1999. doi:10.1056/NEJM199906103402306.
178. Mendelsohn ME, Karas RH. Rapid progress for non-nuclear estrogen receptor signaling. J Clin Invest 120: 2277-2279, 2010. doi:10.1172/JCI43756.
179. Meyer MR, Amann K, Field AS, Hu C, Hathaway HJ, Kanagy NL, Walker MK, Barton M, Prossnitz ER. Deletion of G protein-coupled estrogen receptor increases endothelial vasoconstriction. Hypertension 59: 507-512, 2012. doi:10.1161/HYPERTENSIONAHA.111.184606.
180. Meyer MR, Baretella O, Prossnitz ER, Barton M. Dilation of epicardial coronary arteries by the G protein-coupled estrogen receptor agonists G-1 and ICI 182,780. Pharmacology 86: 58-64, 2010. doi:10.1159/000315497.
181. Meyer MR, Barton M. ERalpha, ERbeta, and gpER: novel aspects of oestrogen receptor signalling in atherosclerosis. Cardiovasc Res 83: 605-610, 2009. doi:10.1093/cvr/cvp187.
182. Meyer MR, Fredette NC, Howard TA, Hu C, Ramesh C, Daniel C, Amann K, Arterburn JB, Barton M, Prossnitz ER. G protein-coupled estrogen receptor protects from atherosclerosis. Sci Rep 4: 7564, 2014. doi:10.1038/srep07564.
183. Meyer MR, Haas E, Barton M. Need for research on estrogen receptor function: importance for postmenopausal hormone therapy and atherosclerosis. Gend Med 5, Suppl A: S19-S33, 2008. doi:10.1016/j.genm. 2008.03.004.
184. Meyer MR, Prossnitz ER, Barton M. The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function. Vascul Pharmacol 55: 17-25, 2011. doi:10.1016/j.vph.2011.06.003.
185. Mhurchu CN, Anderson C, Jamrozik K, Hankey G, Dunbabin D, Longstreth WT, Nelson LM; Australasian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS) Group. Hormonal factors and risk of aneurysmal subarachnoid hemorrhage: an international population-based, case-control study. Stroke 32: 606-612, 2001. doi:10.1161/01.STR.32.3.606.
186. Molácek J, Treska V, Kobr J, Certík B, Skalick T, Kuntscher V, Krízková V. Optimization of the model of abdominal aortic aneurysm-experiment in an animal model. J Vasc Res 46: 1-5, 2008. doi:10.1159/000135659.
187. 2+ channel blockade. Endocrinology 149: 2517-2526, 2008. doi:10.1210/en.2007-1288.
188. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jiménez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER III, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB; Writing Group Members; American Heart Association Statistics Committee; Stroke Statistics Subcommittee. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation 133: e38-e360, 2016. doi:10.1161/CIR.0000000000000350.
189. Muller M, van den Beld AW, Bots ML, Grobbee DE, Lamberts SW, van der Schouw YT. Endogenous sex hormones and progression of carotid atherosclerosis in elderly men. Circulation 109: 2074-2079, 2004. doi:10.1161/01.CIR.0000125854.51637.06.
190. Murphy E. Estrogen signaling and cardiovascular disease. Circ Res 109: 687-696, 2011. doi:10.1161/CIRCRESAHA.110.236687.
191. Nakagawa K, Marji JS, Schwartzman ML, Waterman MR, Capdevila JH. Androgen-mediated induction of the kidney arachidonate hydroxylases is associated with the development of hypertension. Am J Physiol Regul Integr Comp Physiol 284: R1055-R1062, 2003. doi:10.1152/ajpregu.00459.2002.
192. Nakano T, Hurn PD, Herson PS, Traystman RJ. Testosterone exacerbates neuronal damage following cardiac arrest and cardiopulmonary resuscitation in mouse. Brain Res 1357: 124-130, 2010. doi:10.1016/j. brainres.2010.08.013.
193. Nappi RE, Terreno E, Sances G, Martini E, Tonani S, Santamaria V, Tassorelli C, Spinillo A. Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM). Contraception 88: 369-375, 2013. doi:10.1016/j.contraception.2013.02.001.
194. Nathan L, Shi W, Dinh H, Mukherjee TK, Wang X, Lusis AJ, Chaudhuri G. Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase. Proc Natl Acad Sci USA 98: 35893593, 2001. doi:10.1073/pnas.051003698.
195. Nelson PS, Clegg N, Arnold H, Ferguson C, Bonham M, White J, Hood L, Lin B. The program of androgen-responsive genes in neoplastic prostate epithelium. Proc Natl Acad Sci USA 99: 11890-11895, 2002. doi:10.1073/pnas.182376299.
196. Nguyen TV, Yao M, Pike CJ. Androgens activate mitogen-activated protein kinase signaling: role in neuroprotection. J Neurochem 94: 1639-1651, 2005. doi:10.1111/j.1471-4159.2005.03318.x.
197. Nguyen TV, Yao M, Pike CJ. Dihydrotestosterone activates CREB signaling in cultured hippocampal neurons. Brain Res 1298: 1-12, 2009. doi:10.1016/j.brainres.2009.08.066.
198. Niewada M, Kobayashi A, Sandercock PA, Kamiński B, Czlonkowska A; International Stroke Trial Collaborative Group. Influence of gender on baseline features and clinical outcomes among 17,370 patients with confirmed ischaemic stroke in the international stroke trial. Neuroepidemiology 24: 123-128, 2005. doi:10.1159/000082999.
199. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45, Suppl S: S5-S67, 2007. doi:10.1016/j.jvs.2006.12.037.
200. Nurmi A, Lindsberg PJ, Koistinaho M, Zhang W, Juettler E, Karjalainen-Lindsberg ML, Weih F, Frank N, Schwaninger M, Koistinaho J. Nuclear factor-kappaB contributes to infarction after permanent focal ischemia. Stroke 35: 987-991, 2004. doi:10.1161/01. STR.0000120732.45951.26.
201. Okwan-Duodu D, Umpierrez GE, Brawley OW, Diaz R. Obesitydriven inflammation and cancer risk: role of myeloid derived suppressor cells and alternately activated macrophages. Am J Cancer Res 3: 21-33, 2013.
202. Oliver MF, Boyd GS. Effect of bilateral ovariectomy on coronary-artery disease and serum-lipid levels. Lancet 2: 690-694, 1959. doi:10.1016/S0140-6736(59)92129-4.
203. Orshal JM, Khalil RA. Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol 286: R233-R249, 2004. doi:10.1152/ajpregu.00338.2003.
204. Pechère-Bertschi A, Burnier M. Female sex hormones, salt, and blood pressure regulation. Am J Hypertens 17: 994-1001, 2004. doi:10.1016/j.amjhyper.2004.08.009.
205. Pechère-Bertschi A, Maillard M, Stalder H, Brunner HR, Burnier M. Blood pressure and renal haemodynamic response to salt during the normal menstrual cycle. Clin Sci (Lond) 98: 697-702, 2000. doi:10.1042/cs0980697.
206. Pedram A, Razandi M, Aitkenhead M, Hughes CC, Levin ER. Integration of the non-genomic and genomic actions of estrogen. Membrane-initiated signaling by steroid to transcription and cell biology. J Biol Chem 277: 50768-50775, 2002. doi:10.1074/jbc.M210106200.
207. Pelzer T, Jazbutyte V, Hu K, Segerer S, Nahrendorf M, Nordbeck P, Bonz AW, Muck J, Fritzemeier KH, Hegele-Hartung C, Ertl G, Neyses L. The estrogen receptor-alpha agonist 16alpha-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats. Cardiovasc Res 67: 604-612, 2005. doi:10.1016/j.cardiores.2005.04.035.
208. Pérez-López FR, Chedraui P, Gilbert JJ, Pérez-Roncero G. Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-Women’s Health Initiative era. Fertil Steril 92: 1171-1186, 2009. doi:10.1016/j.fertnstert.2009.06.032.
209. Persky RW, Liu F, Xu Y, Weston G, Levy S, Roselli CE, McCullough LD. Neonatal testosterone exposure protects adult male rats from stroke. Neuroendocrinology 97: 271-282, 2013. doi:10.1159/000343804.
210. Peterlin BL, Gupta S, Ward TN, Macgregor A. Sex matters: evaluating sex and gender in migraine and headache research. Headache 51: 839-842, 2011. doi:10.1111/j.1526-4610.2011.01900.x.
211. Petrea RE, Beiser AS, Seshadri S, Kelly-Hayes M, Kase CS, Wolf PA. Gender differences in stroke incidence and poststroke disability in the Framingham heart study. Stroke 40: 1032-1037, 2009. doi:10.1161/STROKEAHA.108.542894.
212. Pike CJ, Nguyen TV, Ramsden M, Yao M, Murphy MP, Rosario ER. Androgen cell signaling pathways involved in neuroprotective actions. Horm Behav 53: 693-705, 2008. doi:10.1016/j.yhbeh.2007.11.006.
213. Pleumeekers HJ, Hoes AW, van der Does E, van Urk H, Hofman A, de Jong PT, Grobbee DE. Aneurysms of the abdominal aorta in older adults. The Rotterdam Study. Am J Epidemiol 142: 1291-1299, 1995. doi:10.1093/oxfordjournals.aje.a117596.
214. Pollow DP, Uhrlaub J, Romero-Aleshire M, Sandberg K, Nikolich-Zugich J, Brooks HL, Hay M. Sex differences in T-lymphocyte tissue infiltration and development of angiotensin II hypertension. Hypertension 64: 384-390, 2014. doi:10.1161/HYPERTENSIONAHA.114. 03581.
215. Qiu Y, Yanase T, Hu H, Tanaka T, Nishi Y, Liu M, Sueishi K, Sawamura T, Nawata H. Dihydrotestosterone suppresses foam cell formation and attenuates atherosclerosis development. Endocrinology 151: 3307-3316, 2010. doi:10.1210/en.2009-1268.
216. Quigley R. Androgens stimulate proximal tubule transport. Gend Med 5, SupplA: S114-S120, 2008. doi:10.1016/j.genm.2008.03.011.
217. Radmayr C, Lunacek A, Schwentner C, Oswald J, Klocker H, Bartsch G. 5-alpha-reductase and the development of the human prostate. Indian J Urol 24: 309-312, 2008. doi:10.4103/0970-1591.42610.
218. Raju TN, Nelson KB, Ferriero D, Lynch JK; NICHD-NINDS Perinatal Stroke Workshop Participants. Ischemic perinatal stroke: summary of a workshop sponsored by the National Institute of Child Health and Human Development and the National Institute of Neurological Disorders and Stroke. Pediatrics 120: 609-616, 2007. doi:10.1542/peds. 2007-0336.
219. Rauschemberger MB, Sandoval MJ, Massheimer VL. Cellular and molecular actions displayed by estrone on vascular endothelium. Mol CellEndocrinol 339: 136-143, 2011. doi:10.1016/j.mce.2011.04.009.
220. Reckelhoff JF. Polycystic ovary syndrome: androgens and hypertension. Hypertension 49: 1220-1221, 2007. doi:10.1161/HYPERTENSIONAHA. 107.088138.
221. Reeves MJ, Bushnell CD, Howard G, Gargano JW, Duncan PW, Lynch G, Khatiwoda A, Lisabeth L. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol 7: 915-926, 2008. doi:10.1016/S1474-4422(08)70193-5.
222. Rettew JA, McCall SH IV, Marriott I. GPR30/GPER-1 mediates rapid decreases in TLR4 expression on murine macrophages. Mol Cell Endocrinol 328: 87-92, 2010. doi:10.1016/j.mce.2010.07.017.
223. Rifici VA, Khachadurian AK. The inhibition of low-density lipoprotein oxidation by 17-beta estradiol. Metabolism 41: 1110-1114, 1992. doi: 10.1016/0026-0495(92)90295-L.
224. Rodriguez-Acevedo AJ, Maher BH, Lea RA, Benton M, Griffiths LR. Association of oestrogen-receptor gene (ESR1) polymorphisms with migraine in the large Norfolk Island pedigree. Cephalalgia 33: 11391147, 2013. doi:10.1177/0333102413486321.
225. Roquer J, Campello AR, Gomis M. Sex differences in first-ever acute stroke. Stroke 34: 1581-1585, 2003. doi:10.1161/01.STR.0000078562. 82918.F6.
226. Rubanyi GM, Freay AD, Kauser K, Sukovich D, Burton G, Lubahn DB, Couse JF, Curtis SW, Korach KS. Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. Gender difference and effect of estrogen receptor gene disruption. J Clin Invest 99: 2429-2437, 1997. doi:10.1172/JCI119426.
227. Ruifrok WP, de Boer RA, Iwakura A, Silver M, Kusano K, Tio RA, Losordo DW. Estradiol-induced, endothelial progenitor cell-mediated neovascularization in male mice with hind-limb ischemia. Vasc Med 14: 29-36, 2009. doi:10.1177/1358863X08096666.
228. Rupec RA, Baeuerle PA. The genomic response of tumor cells to hypoxia and reoxygenation. Differential activation of transcription factors AP-1 and NF-kappa B. Eur J Biochem 234: 632-640, 1995. doi:10.1111/j.1432-1033.1995.632_b.x.
229. Saleh MC, Connell BJ, Saleh TM. Autonomic and cardiovascular reflex responses to central estrogen injection in ovariectomized female rats. Brain Res 879: 105-114, 2000. doi:10.1016/S0006-8993(00)02757-8.
230. Saleh MC, Connell BJ, Saleh TM. Medullary and intrathecal injections of 17beta-estradiol in male rats. Brain Res 867: 200-209, 2000. doi:10.1016/S0006-8993(00)02313-1.
231. Sanberg PR, Saporta S, Borlongan CV, Othberg AI, Allen RC, Cameron DF. The testis-derived cultured Sertoli cell as a natural Fas-L secreting cell for immunosuppressive cellular therapy. Cell Transplant 6: 191-193, 1997.
232. Sandberg K, Ji H. Sex differences in primary hypertension. Biol Sex Differ 3: 7, 2012. doi:10.1186/2042-6410-3-7.
233. Saraff K, Babamusta F, Cassis LA, Daugherty A. Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin Il-infused, apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 23: 1621-1626, 2003. doi:10.1161/01.ATV.0000085631.76095.64.
234. Schulster M, Bernie AM, Ramasamy R. The role of estradiol in male reproductive function. Asian J Androl 18: 435-40, 2016. doi:10.4103/1008-682X.173932.
235. Seyrek M, Yildiz O, Ulusoy HB, Yildirim V. Testosterone relaxes isolated human radial artery by potassium channel opening action. J Pharmacol Sci 103: 309-316, 2007. doi:10.1254/jphs.FP0060883.
236. Sharma G, Hu C, Brigman JL, Zhu G, Hathaway HJ, Prossnitz ER. GPER deficiency in male mice results in insulin resistance, dyslipidemia, and a proinflammatory state. Endocrinology 154: 4136-4145, 2013. doi:10.1210/en.2013-1357.
237. Sheiner E, Levy A, Katz M, Hershkovitz R, Leron E, Mazor M. Gender does matter in perinatal medicine. Fetal Diagn Ther 19: 366369, 2004. doi:10.1159/000077967.
238. Shih CD. Activation of estrogen receptor beta-dependent nitric oxide signaling mediates the hypotensive effects of estrogen in the rostral ventrolateral medulla of anesthetized rats. J Biomed Sci 16: 60, 2009. doi:10.1186/1423-0127-16-60.
239. Shihan M, Bulldan A, Scheiner-Bobis G. Non-classical testosterone signaling is mediated by a G-protein-coupled receptor interacting with Gna11. Biochim Biophys Acta 1843: 1172-1181, 2014. doi:10.1016/j. bbamcr.2014.03.002.
240. Sieveking DP, Lim P, Chow RW, Dunn LL, Bao S, McGrath KC, Heather AK, Handelsman DJ, Celermajer DS, Ng MK. A sex-specific role for androgens in angiogenesis. J Exp Med 207: 345-352, 2010. doi:10.1084/jem.20091924.
241. Sigvant B, Wiberg-Hedman K, Bergqvist D, Rolandsson O, Andersson B, Persson E, Wahlberg E. A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. J Vasc Surg 45: 1185-1191, 2007. doi:10.1016/j. jvs.2007.02.004.
242. Simoncini T, De Caterina R, Genazzani AR. Selective estrogen receptor modulators: different actions on vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells. J Clin Endocrinol Metab 84: 815-818, 1999. doi:10.1210/jcem.84.2.5570.
243. Singh H, Schwartzman ML. Renal vascular cytochrome P450-derived eicosanoids in androgen-induced hypertension. Pharmacol Rep 60: 29-37, 2008.
244. Somerville BW. Estrogen-withdrawal migraine. I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration. Neurology 25: 239-244, 1975. doi:10.1212/WNL.25.3.239.
245. Spary EJ, Maqbool A, Batten TF. Oestrogen receptors in the central nervous system and evidence for their role in the control of cardiovascular function. J Chem Neuroanat 38: 185-196, 2009. doi:10.1016/j. jchemneu.2009.05.008.
246. Srivastava RA. Estrogen-induced regulation of the ATP-binding cassette transporter A1 (ABCA1) in mice: a possible mechanism of atheroprotection by estrogen. Mol Cell Biochem 240: 67-73, 2002. doi:10.1023/A:1020604610873.
247. Stangl H, Graf GA, Yu L, Cao G, Wyne K. Effect of estrogen on scavenger receptor BI expression in the rat. J Endocrinol 175: 663-672, 2002. doi:10.1677/joe.0.1750663.
248. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 267: 64-69, 1992. doi:10.1001/jama.1992.03480010072027.
249. Stirone C, Boroujerdi A, Duckles SP, Krause DN. Estrogen receptor activation of phosphoinositide-3 kinase, akt, and nitric oxide signaling in cerebral blood vessels: rapid and long-term effects. Mol Pharmacol 67: 105-113, 2005. doi:10.1124/mol.104.004465.
250. Stovner L, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, Steiner T, Zwart JA. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27: 193210, 2007. doi:10.1111/j.1468-2982.2007.01288.x.
251. Sugioka K, Shimosegawa Y, Nakano M. Estrogens as natural antioxidants of membrane phospholipid peroxidation. FEBS Lett 210: 37-39, 1987. doi:10.1016/0014-5793(87)81293-0.
252. Sulistiyani, St Clair RW. Effect of 17 beta-estradiol on metabolism of acetylated low-density lipoprotein by THP-1 macrophages in culture. Arterioscler Thromb Vasc Biol 17: 1691-1700, 1997. doi:10.1161/01. ATV.17.9.1691.
253. Suzuki S, Brown CM, Wise PM. Neuroprotective effects of estrogens following ischemic stroke. Front Neuroendocrinol 30: 201-211, 2009. doi:10.1016/j.yfrne.2009.04.007.
254. Tada Y, Makino H, Furukawa H, Shimada K, Wada K, Liang EI, Murakami S, Kudo M, Kung DK, Hasan DM, Kitazato KT, Nagahiro S, Lawton MT, Hashimoto T. Roles of estrogen in the formation of intracranial aneurysms in ovariectomized female mice. Neurosurgery 75: 690-695, 2014. doi:10.1227/NEU.0000000000000528.
255. Tada Y, Wada K, Shimada K, Makino H, Liang EI, Murakami S, Kudo M, Shikata F, Pena Silva RA, Kitazato KT, Hasan DM, Kanematsu Y, Nagahiro S, Hashimoto T. Estrogen protects against intracranial aneurysm rupture in ovariectomized mice. Hypertension 63: 1339-1344, 2014. doi:10.1161/HYPERTENSIONAHA.114.03300.
256. Tamura T, Jamous MA, Kitazato KT, Yagi K, Tada Y, Uno M, Nagahiro S. Endothelial damage due to impaired nitric oxide bioavailability triggers cerebral aneurysm formation in female rats. J Hypertens 27: 1284-1292, 2009. doi:10.1097/HJH.0b013e328329d1a7.
257. Taylor JM, Borthwick F, Bartholomew C, Graham A. Overexpression of steroidogenic acute regulatory protein increases macrophage cholesterol efflux to apolipoprotein AI. Cardiovasc Res 86: 526-534, 2009. doi:10.1093/cvr/cvq015.
258. Tenenbaum M, Azab AN, Kaplanski J. Effects of estrogen against LPS-induced inflammation and toxicity in primary rat glial and neuronal cultures. J Endotoxin Res 13: 158-166, 2007. doi:10.1177/0968051907080428.
259. 2+ homeostasis alteration in human endothelial cells. Vascul Pharmacol 53: 230-238, 2010. doi:10.1016/j.vph.2010.09.001.
260. Tobinick E, Kim NM, Reyzin G, Rodriguez-Romanacce H, DePuy V. Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept. CNS Drugs 26: 1051-1070, 2012. doi:10.1007/s40263-012-0013-2.
261. Trigatti BL, Fuller M. HDL signaling and protection against coronary artery atherosclerosis in mice. J Biomed Res 30: 94-100, 2015. doi:10.7555/JBR.30.20150079.
262. Tunstall-Pedoe H, Kuulasmaa K, Mähönen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 353: 1547-1557, 1999. doi:10.1016/S0140-6736(99)04021-0.
263. Turin TC, Okamura T, Afzal AR, Rumana N, Watanabe M, Higashiyama A, Nakao Y, Nakai M, Takegami M, Nishimura K, Kokubo Y, Okayama A, Miyamoto Y. Hypertension and lifetime risk of stroke. J Hypertens 34: 116-122, 2016. doi:10.1097/HJH.0000000000000753.
264. Uchida M, Palmateer JM, Herson PS, DeVries AC, Cheng J, Hurn PD. Dose-dependent effects of androgens on outcome after focal cerebral ischemia in adult male mice. J Cereb Blood Flow Metab 29: 1454-1462, 2009. doi:10.1038/jcbfm.2009.60.
265. van den Beld AW, Bots ML, Janssen JA, Pols HA, Lamberts SW, Grobbee DE. Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol 157: 25-31, 2003. doi:10.1093/aje/kwf160.
266. Vasan RS, Larson MG, Leip EP, Evans JC, O’Donnell CJ, Kannel WB, Levy D. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 345: 1291-1297, 2001. doi:10.1056/NEJMoa003417.
267. Villablanca A, Lubahn D, Shelby L, Lloyd K, Barthold S. Susceptibility to early atherosclerosis in male mice is mediated by estrogen receptor alpha. Arterioscler Thromb Vasc Biol 24: 1055-1061, 2004. doi:10.1161/01.ATV.0000130467.65290.d4.
268. Villablanca AC, Jayachandran M, Banka C. Atherosclerosis and sex hormones: current concepts. Clin Sci (Lond) 119: 493-513, 2010. doi: 10.1042/CS20100248.
269. Villablanca AC, Tenwolde A, Lee M, Huck M, Mumenthaler S, Rutledge JC. 17beta-estradiol prevents early-stage atherosclerosis in estrogen receptor-alpha deficient female mice. J Cardiovasc Transl Res 2: 289-299, 2009. doi:10.1007/s12265-009-9103-z.
270. Vitale C, Mendelsohn ME, Rosano GM. Gender differences in the cardiovascular effect of sex hormones. Nat Rev Cardiol 6: 532-542, 2009. doi:10.1038/nrcardio.2009.105.
271. Wagner AH, Schroeter MR, Hecker M. 17beta-estradiol inhibition of NADPH oxidase expression in human endothelial cells. FASEB J 15: 2121-2130, 2001. doi:10.1096/fj.01-0123com.
272. Walsh BA, Mullick AE, Walzem RL, Rutledge JC. 17Beta-estradiol reduces tumor necrosis factor-alpha-mediated LDL accumulation in the artery wall. J Lipid Res 40: 387-396, 1999.
273. Walsh BW, Li H, Sacks FM. Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism. J Lipid Res 35: 2083-2093, 1994.
274. Wang G, Drake CT, Rozenblit M, Zhou P, Alves SE, Herrick SP, Hayashi S, Warrier S, Iadecola C, Milner TA. Evidence that estrogen directly and indirectly modulates C1 adrenergic bulbospinal neurons in the rostral ventrolateral medulla. Brain Res 1094: 163-178, 2006. doi: 10.1016/j.brainres.2006.03.089.
275. Wang H, Jessup JA, Zhao Z, Da Silva J, Lin M, MacNamara LM, Ahmad S, Chappell MC, Ferrario CM, Groban L. Characterization of the cardiac renin angiotensin system in oophorectomized and estrogen-replete mRen2.Lewis rats. PLoS One 8: e76992, 2013. doi:10.1371/journal.pone.0076992.
276. Wang JM, Irwin RW, Brinton RD. Activation of estrogen receptor alpha increases and estrogen receptor beta decreases apolipoprotein E expression in hippocampus in vitro and in vivo. Proc Natl Acad Sci USA 103: 16983-16988, 2006. doi:10.1073/pnas.0608128103.
277. Wang SJ, Fuh JL, Lu SR, Juang KD, Wang PH. Migraine prevalence during menopausal transition. Headache 43: 470-78, 2003. doi:10.1046/j.1526-4610.2003.03092.x.
278. Wang Y, Rudd AG, Wolfe CD. Age and ethnic disparities in incidence of stroke over time: the South London Stroke Register. Stroke 44: 3298-3304, 2013. doi:10.1161/STROKEAHA.113.002604.
279. Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 8: II127-II134, 1986. doi:10.1161/01.HYP.8.6_ Pt_2.II127.
280. Wilson CM, McPhaul MJ. A and B forms of the androgen receptor are expressed in a variety of human tissues. Mol Cell Endocrinol 120: 51-57, 1996. doi:10.1016/0303-7207(96)03819-1.
281. Wu CC, Cheng J, Zhang FF, Gotlinger KH, Kelkar M, Zhang Y, Jat JL, Falck JR, Schwartzman ML. Androgen-dependent hypertension is mediated by 20-hydroxy-5,8,11,14-eicosatetraenoic acid-induced vascular dysfunction: role of inhibitor of kappaB Kinase. Hypertension 57: 788-794, 2011. doi:10.1161/HYPERTENSIONAHA.110.161570.
282. Wu XF, Zhang J, Paskauskas S, Xin SJ, Duan ZQ. The role of estrogen in the formation of experimental abdominal aortic aneurysm. Am J Surg 197: 49-54, 2009. doi:10.1016/j.amjsurg.2007.11.022.
283. Xiao X, Zhang C, Ma X, Miao H, Wang J, Liu L, Chen S, Zeng R, Chen Y, Bihl JC. Angiotensin-(1-7) counteracts angiotensin II-induced dysfunction in cerebral endothelial cells via modulating Nox2/ROS and PI3K/NO pathways. Exp Cell Res 336: 58-65, 2015. doi:10.1016/j. yexcr.2015.06.010.
284. Xing D, Feng W, Miller AP, Weathington NM, Chen YF, Novak L, Blalock JE, Oparil S. Estrogen modulates TNF-alpha-induced inflammatory responses in rat aortic smooth muscle cells through estrogen receptor-beta activation. Am J Physiol Heart Circ Physiol 292: H2607-H2612, 2007. doi:10.1152/ajpheart.01107.2006.
285. Xue B, Badaue-Passos D Jr, Guo F, Gomez-Sanchez CE, Hay M, Johnson AK. Sex differences and central protective effect of 17betaestradiol in the development of aldosterone/NaCl-induced hypertension. Am J Physiol Heart Circ Physiol 296: H1577-H1585, 2009. doi:10.1152/ajpheart.01255.2008.
286. Xue B, Beltz TG, Johnson RF, Guo F, Hay M, Johnson AK. PVN adenovirus-siRNA injections silencing either NOX2 or NOX4 attenuate aldosterone/NaCl-induced hypertension in mice. Am J Physiol Heart Circ Physiol 302: H733-H741, 2012. doi:10.1152/ajpheart.00873.2011.
287. Xue B, Beltz TG, Yu Y, Guo F, Gomez-Sanchez CE, Hay M, Johnson AK. Central interactions of aldosterone and angiotensin II in aldosterone- and angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol 300: H555-H564, 2011. doi:10.1152/ajpheart.00847.2010.
288. Xue B, Pamidimukkala J, Lubahn DB, Hay M. Estrogen receptor-alpha mediates estrogen protection from angiotensin II-induced hypertension in conscious female mice. Am J Physiol Heart Circ Physiol 292: H1770-H1776, 2007. doi:10.1152/ajpheart.01011.2005.
289. Xue B, Singh M, Guo F, Hay M, Johnson AK. Protective actions of estrogen on angiotensin II-induced hypertension: role of central nitric oxide. Am J Physiol Heart Circ Physiol 297: H1638-H1646, 2009. doi:10.1152/ajpheart.00502.2009.
290. Xue B, Zhang Z, Beltz TG, Guo F, Hay M, Johnson AK. Estrogen regulation of the brain renin-angiotensin system in protection against angiotensin II-induced sensitization of hypertension. Am J Physiol Heart Circ Physiol 307: H191-H198, 2014. doi:10.1152/ajpheart.01012.2013.
291. Xue B, Zhang Z, Beltz TG, Johnson RF, Guo F, Hay M, Johnson AK. Estrogen receptor-p in the paraventricular nucleus and rostroventrolateral medulla plays an essential protective role in aldosterone/salt-induced hypertension in female rats. Hypertension 61: 1255-1262, 2013. doi:10.1161/HYPERTENSIONAHA.111.00903.
292. Xue B, Zhao Y, Johnson AK, Hay M. Central estrogen inhibition of angiotensin II-induced hypertension in male mice and the role of reactive oxygen species. Am J Physiol Heart Circ Physiol 295: H1025-H1032, 2008. doi:10.1152/ajpheart.00021.2008.
293. Yanes LL, Reckelhoff JF. Postmenopausal hypertension. Am J Hypertens 24: 740-749, 2011. doi:10.1038/ajh.2011.71.
294. Yeap BB, Alfonso H, Chubb SA, Handelsman DJ, Hankey GJ, Golledge J, Flicker L, Norman PE. Lower plasma testosterone or dihydrotestosterone, but not estradiol, is associated with symptoms of intermittent claudication in older men. Clin Endocrinol (Oxf) 79: 725732, 2013.
295. Yeap BB, Hyde Z, Almeida OP, Norman PE, Chubb SA, Jamrozik K, Flicker L, Hankey GJ. Lower testosterone levels predict incident stroke and transient ischemic attack in older men. J Clin Endocrinol Metab 94: 2353-2359, 2009. doi:10.1210/jc.2008-2416.
296. Yoshida S, Aihara K, Ikeda Y, Sumitomo-Ueda Y, Uemoto R, Ishikawa K, Ise T, Yagi S, Iwase T, Mouri Y, Sakari M, Matsumoto T, Takeyama K, Akaike M, Matsumoto M, Sata M, Walsh K, Kato S, Matsumoto T. Androgen receptor promotes sex-independent angiogenesis in response to ischemia and is required for activation of vascular endothelial growth factor receptor signaling. Circulation 128: 60-71, 2013. doi:10.1161/CIRCULATIONAHA.113.001533.
297. Youssef MY, Alqallaf A, Abdella N. Anabolic androgenic steroidinduced cardiomyopathy, stroke and peripheral vascular disease. BMJ Case Rep 2011, jun30 1: bcr1220103650, 2011. doi:10.1136/bcr.12. 2010.3650.
298. Yu J, Akishita M, Eto M, Koizumi H, Hashimoto R, Ogawa S, Tanaka K, Ouchi Y, Okabe T. Src kinase-mediates androgen receptor-dependent non-genomic activation of signaling cascade leading to endothelial nitric oxide synthase. Biochem Biophys Res Commun 424: 538543, 2012. doi:10.1016/j.bbrc.2012.06.151.
299. Yu J, Akishita M, Eto M, Ogawa S, Son BK, Kato S, Ouchi Y, Okabe T. Androgen receptor-dependent activation of endothelial nitric oxide synthase in vascular endothelial cells: role of phosphatidylinositol 3-kinase/akt pathway. Endocrinology 151: 1822-1828, 2010. doi:10.1210/en.2009-1048.
300. Zhang X, Thatcher S, Wu C, Daugherty A, Cassis LA. Castration of male mice prevents the progression of established angiotensin II-induced abdominal aortic aneurysms. J Vasc Surg 61: 767-776, 2015. doi:10.1016/j.jvs.2013.11.004.
301. Zhang X, Thatcher SE, Rateri DL, Bruemmer D, Charnigo R, Daugherty A, Cassis LA. Transient exposure of neonatal female mice to testosterone abrogates the sexual dimorphism of abdominal aortic aneurysms. Circ Res 110: e73-e85, 2012. doi:10.1161/CIRCRESAHA.111. 253880.
302. Zhang ZH, Yu Y, Kang YM, Wei SG, Felder RB. Aldosterone acts centrally to increase brain renin-angiotensin system activity and oxidative stress in normal rats. Am J Physiol Heart Circ Physiol 294: H1067-H1074, 2008. doi:10.1152/ajpheart.01131.2007.
303. Zhu Y, Bian Z, Lu P, Karas RH, Bao L, Cox D, Hodgin J, Shaul PW, Thoren P, Smithies O, Gustafsson JA, Mendelsohn ME. Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 295: 505-508, 2002. doi:10.1126/science.1065250.